These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 170227)

  • 1. Narcotic antagonists: a reasonable method of treating narcotic dependency.
    Schooff KG; Hersch RG; Keegan JF
    Int J Addict; 1975; 10(3):391-400. PubMed ID: 170227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled study using cyclazocine in the treatment of narcotic addiction.
    Chappel JN; Jaffe JH; Senay EC
    Am J Drug Alcohol Abuse; 1974; 1(2):233-42. PubMed ID: 4619540
    [No Abstract]   [Full Text] [Related]  

  • 3. Methadone maintenance and narcotic blocking drugs.
    Wikler A
    Int J Addict; 1977 Oct; 12(7):851-6. PubMed ID: 201577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experiences with narcotic antagonists: cyclazocine and naloxone.
    Proc Natl Conf Methadone Treat; 1973; 1():447-51. PubMed ID: 4808183
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
    Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
    Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonist study in St. Louis.
    Parwatikar S; Crawford J; Unverdi C
    Am J Drug Alcohol Abuse; 1975; 2(3-4):379-90. PubMed ID: 1227299
    [No Abstract]   [Full Text] [Related]  

  • 7. A new antagonist treatment program for narcotic addicts (the first Antagonist-Inmate Work Release Program).
    Brahen LS; Capone T; Wiechert V
    Proc Natl Conf Methadone Treat; 1973; 1():401-4. PubMed ID: 4808175
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclazocine and methadone in narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical usefulness of narcotic antagonists: implications of behavioral research.
    Meyer RE; Mirin SM; Altman JL
    Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose cyclazocine therapy of opiate dependence.
    Resnick R; Fink M; Freedman AM
    Am J Psychiatry; 1974 May; 131(5):595-7. PubMed ID: 4594561
    [No Abstract]   [Full Text] [Related]  

  • 11. A behavioral paradigm for the evaluation of narcotic antagonists.
    Meyer RE; Mirin SM; Altman JL; McNamee HB
    Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone maintenance and narcotic blocking drugs. Appendix.
    Wikler A
    Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
    Resnick RB; Schuyten-Resnick E; Washton AM
    Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of EN-1639A (naltrexone): a new narcotic antagonist.
    Resnick RB; Volavka J; Freedman AM; Thomas M
    Am J Psychiatry; 1974 Jun; 131(6):646-50. PubMed ID: 4827793
    [No Abstract]   [Full Text] [Related]  

  • 15. NIDA's naltrexone research program.
    Julius D
    NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospects, problems, side effects, and safety of narcotic antagonists.
    Resnick RB
    Int J Addict; 1977 Oct; 12(7):863-7. PubMed ID: 591144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of cyclazocine in the treatment of heroin addicts.
    Petursson ES; Preble E
    Dis Nerv Syst; 1970 Aug; 31(8):549-51. PubMed ID: 5471792
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclazocine treatment for heroin addicts.
    Kissin B; Ottomanelli G; Sang E; Halloran G
    Proc Natl Conf Methadone Treat; 1973; 1():658-66. PubMed ID: 4808217
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis and modification of opiate reinforcement.
    Meyer RE; McNamee HB; Mirin SM; Altman JL
    Int J Addict; 1976; 11(3):467-84. PubMed ID: 184053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist Inmate Work-Release Program behavioral research design.
    Capone T; Brahen LS; Wiechert V
    Proc Natl Conf Methadone Treat; 1973; 1():405-10. PubMed ID: 4808176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.